Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Laureen A. Green-Gallo"'
Autor:
Wayne J. Ivusich, Mukund S. Didolkar, James H. Resau, Neil Caporaso, Karen L. Fisher, Laureen A. Green-Gallo, Robert G. Slawson, Daina M. Buivys, E. George Elias
Publikováno v:
Cancer. 68:206-210
The genetically determined ability to metabolize the antihypertensive drug debrisoquine has been proposed as a genetic risk factor for primary carcinomas of the lung. To test this hypothesis, the metabolism of the drug was evaluated in a case control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59e6c8228a0bc293524a35f68b452978
https://doi.org/10.1002/1097-0142(19910701)68:1<206::aid-cncr2820680138>3.0.co
https://doi.org/10.1002/1097-0142(19910701)68:1<206::aid-cncr2820680138>3.0.co
Autor:
Aimsley Weston, Gary M. Muschik, Linda W. Pickle, Neil E. Caporaso, Haleem J. Issaq, David J. Tollerud, Benjamin F. Trump, Seena C. Aisner, Margaret A. Tucker, Daina Buivys, Curtis C. Harris, James H. Resau, Robert N. Hoover, Richard B. Hayes, Laureen A. Green-Gallo
Publikováno v:
Journal of the National Cancer Institute. 82(15)
In a case-control study, we tested the hypothesis that the genetically determined ability to metabolize debrisoquine is related to risk of lung cancer. Overall, individuals who were extensive metabolizers of debrisoquine were at significantly greater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72143ba135697cff67871e1455eb365d
https://pubmed.ncbi.nlm.nih.gov/2374172
https://pubmed.ncbi.nlm.nih.gov/2374172